Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019888 · ClinicalTrials.gov registry record
Wide Frequency Band Test of Hearing in Veterans
A clinical trial of Hearing Loss, Sensorineural and Otitis Media With Effusion, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 320
- Enrollment target
- 2
- Study locations
NCT02019888: Completed study of Hearing Loss, Sensorineural and Otitis Media With Effusion, sponsored by VA Office of Research and Development.
NCT02019888 is a study of Hearing Loss, Sensorineural and Otitis Media With Effusion that has completed, run by VA Office of Research and Development. The registered enrollment target is 320 participants, below the 770-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (58% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02019888, a study of Hearing Loss, Sensorineural and Otitis Media With Effusion, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 320 participants
- Enrollment target
- 2
- Study locations
Study Summary
The accurate assessment of auditory status is critical for planning treatment for Veterans with hearing loss to include medical and audiological management. Current physiologic tests of auditory function in the standard clinical audiological test battery for Veterans have limited sensitivity in detecting some middle-ear disorders, and do not include a direct test of cochlear function. Recent studies have shown promise for new wide-bandwidth (WB) tests of absorbance for improved sensitivity in the assessment of middle-ear function including acoustic reflex testing. The addition of WB tests of cochlear function included in the WB test battery provides an opportunity to improve audiological diagnosis of a range of hearing disorders in Veterans. The automation provided by the WB test battery could provide additional benefits in reducing the duration of the evaluation, leaving more time for evaluation of test findings and counseling. Results from this study may lead to the improvement of audiological care for Veterans with hearing loss.
Primary Outcome
Ambient Wideband Absorbance is the experimental middle ear test. Results were compared to the Secondary Outcome Measure of Clinical Peak Static Acoustic Admittance. Wideband absorbance was averaged across frequencies from 250 to 8000 Hz on a ratio scale from 0 to 1. In general, higher absorbance is indicative of a better outcome (i.e., better middle ear function).
Conditions Studied
Study Locations (2)
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Tennessee
- Mountain Home VA Medical Center James H. Quillen VA Medical Center, Mountain Home, TN - Mountain Home
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2014-12-01 |
| Est. Completion | 2020-01-31 |
What the finished NCT02019888 record still lists
NCT02019888 is an observational study that tracks outcomes without assigning an intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 770-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (58% lower).
The record links to 7 conditions, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 0 interventions.
NCT02019888 reports a single indexed study location in Oregon, Tennessee.
Frequently Asked Questions
What is clinical trial NCT02019888 about?
NCT02019888 is a clinical study titled "Wide Frequency Band Test of Hearing in Veterans". The accurate assessment of auditory status is critical for planning treatment for Veterans with hearing loss to include medical and audiological management. Current physiologic tests of auditory function in the standard clinical audiological test battery for Veterans have limited sensitivity in dete...
What is the current status of trial NCT02019888?
This trial is currently completed. The enrollment target is 320 participants. The study started on 2014-12-01. Estimated completion is 2020-01-31.
What conditions does trial NCT02019888 study?
This clinical trial studies the following conditions: Hearing Loss, Sensorineural, Otitis Media With Effusion, Hearing Loss, Conductive, Tympanic Membrane Perforation, Hearing Loss, Mixed Conductive-Sensorineural.
Who is sponsoring clinical trial NCT02019888?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02019888 being conducted?
This trial has 2 study locations across Oregon, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Sensorineural
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02019888's enrollment target sits among peer trials
320 4th of 20 higher than 17 of 20 other Hearing Loss, Sensorineural trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss, Sensorineural trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
-
Barriers and Facilitators to OTC Hearing Aids Success
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
-
Listening Effort in Cochlear Implant Users
RECRUITING · NA
-
Post-Market Clinical Investigation of the IotaSOFT Insertion System
RECRUITING
-
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI